Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
858 Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
858 Therapeutics

858 Therapeutics

Series A

858 Therapeutics: Innovating small molecule drugs for oncology, focusing on RNA regulation and immune response.

HQ
San Diego, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded by a veteran team with a successful track record in pharma and biotech drug discovery, 858 Therapeutics is a biotechnology company focused on developing small molecule drugs targeting novel therapeutic areas. Their core mission is to innovate treatments in oncology, neuroscience, and cardiovascular disease by focusing on synthetic lethality, innate immunity, and RNA modulation. The company aims to address unmet medical needs through cutting-edge drug discovery and development.

Notable affiliated individuals include experienced leaders from the pharmaceutical and biotech industries. 858 Therapeutics has garnered attention for its pioneering approach to targeting RNA regulation and the immune response in cancer therapy. Their key achievements include advancing a robust pipeline of drug candidates and securing strategic partnerships. The overall impact of 858 Therapeutics lies in its potential to transform treatment paradigms for serious diseases, offering new hope to patients worldwide.

858 Therapeutics - Similar Companies

Remix Therapeutics logo

Remix Therapeutics

Expansion Therapeutics logo

Expansion Therapeutics

expansionrx.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Rnav8 Bio logo

Rnav8 Bio

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Rgenta Therapeutics logo

Rgenta Therapeutics

rgentatx.com

Arrakis Therapeutics logo

Arrakis Therapeutics

arrakistx.com

Altay Therapeutics logo

Altay Therapeutics

Rnaderm Therapeutics logo

Rnaderm Therapeutics

Nextrna Therapeutics logo

Nextrna Therapeutics

Palm Therapeutics logo

Palm Therapeutics

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

BlossomHill Therapeutics logo

BlossomHill Therapeutics

bhtherapeutics.com

Exo Therapeutics logo

Exo Therapeutics

858 Therapeutics - Quick Facts

Who are 858 Therapeutics' competitors?

Companies similar to 858 Therapeutics include Remix Therapeutics, Expansion Therapeutics, ReviR Therapeutics and Synnovation Therapeutics.

When was 858 Therapeutics founded?

858 Therapeutics was founded in 2019.

Where is 858 Therapeutics' headquarters located?

858 Therapeutics' headquarters is located in San Diego, CA, US.

When was 858 Therapeutics' last funding round?

858 Therapeutics' most recent funding round was for $60M (USD) in September 2021.

How much has 858 Therapeutics raised to-date?

As of Sep 21, 2021, 858 Therapeutics has raised a total of $80.1M (USD).

How many employees does 858 Therapeutics have?

858 Therapeutics has 27 employees as of Feb 5, 2024.

858 Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified